{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:36:01Z","timestamp":1754163361289,"version":"3.41.2"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate gender-specific variations in cardiovascular disease (CVD) risk stratification and its modifiable determinants among individuals concurrently diagnosed with type 2 diabetes mellitus (T2DM) and subclinical hypothyroidism (SCH).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cross-sectional observational study was conducted involving 2,357 patients with T2DM (1,120 males and 1,237 females) who were hospitalized at Wuxi Hospital of Traditional Chinese Medicine between 2018 and 2024. Participants were categorized into the SCH (n=196) and the euthyroid subgroups (n=2,161). The 10-year probability of cardiovascular events was estimated based on the Framingham Risk Score (FRS) model. Sex-specific differences in SCH prevalence and CVD risk were examined, and associations between FRS and biomarkers\u2014namely thyroid-stimulating hormone (TSH), free thyroxine (FT4), cystatin C (CysC) and other factors\u2014were analyzed via Spearman\u2019s correlation analysis and multivariable linear regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The prevalence of SCH in T2DM patients was 9.06% (10.02% in females vs. 6.43% in males). Male patients diagnosed with SCH exhibited an elevated FRS compared to their euthyroid counterparts (21.00 vs. 20.00, <jats:italic>P=<\/jats:italic> 0.025). Within this subgroup, a positive relationship was identified between TSH levels and FRS(r=0.374, <jats:italic>P=<\/jats:italic> 0.001), whereas FT4 showed a negative association (<jats:italic>r=<\/jats:italic>-0.342, <jats:italic>P=<\/jats:italic> 0.003). These relationships were not statistically significant among women diagnosed with SCH. Cystatin C was positively associated with FRS in both male (<jats:italic>r=<\/jats:italic>0.461, <jats:italic>P&amp;lt;<\/jats:italic>0.001) and female (<jats:italic>r=<\/jats:italic>0.452, <jats:italic>P&amp;lt;<\/jats:italic>0.001) groups. Multivariable linear regression evaluation in male patients revealed that TSH (<jats:italic>\u03b2=<\/jats:italic>3.87, <jats:italic>P=<\/jats:italic> 0.048), cystatin C (<jats:italic>\u03b2=<\/jats:italic>1.48, <jats:italic>P=<\/jats:italic> 0.03), and FT4 (<jats:italic>\u03b2=<\/jats:italic>-0.61, <jats:italic>P=<\/jats:italic> 0.011) continued to be significantly correlated with 10-year CVD risk. Additionally, male patients with SCH exhibited significantly higher smoking status, uric acid, and creatinine levels than their female counterparts (all <jats:italic>P&amp;lt;<\/jats:italic>0.05), indicating that sex-specific risk factors may contribute to elevated CVD risk.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study identified higher FRS in male versus female patients with comorbid T2DM and SCH, potentially mediated by sex-specific variations in TSH, FT4, and CysC levels. These results underscore the importance of implementing sex-specific strategies for CVD risk management in this population.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1635444","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T04:10:54Z","timestamp":1753935054000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Sex differences in 10-year cardiovascular risk of patients with type 2 diabetes mellitus and subclinical hypothyroidism: a cross-sectional study"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiwan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tcm.2019.02.011","article-title":"Subclinical thyroid dysfunction and cardiovascular consequences: an alarming wake-up call","volume":"30","author":"Manolis","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","article-title":"Prevalence of cardiovascular disease in type 2 diabetes: A systematic literature review of scientific evidence from across the world in 2007-2017","volume":"17","author":"Einarson","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.04.012","article-title":"Prevalence of thyroid disorders among patients with diabetes in rural south India","volume":"15","author":"Yadav","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12724","article-title":"Subclinical hypothyroidism and the associations with macrovascular complications and chronic kidney disease in patients with type 2 diabetes","volume":"32","author":"Jia","year":"2015","journal-title":"Diabetes Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-022-01969-x","article-title":"The relationship between thyroid dysfunction, cardiovascular morbidity and mortality in type 2 diabetes: the fremantle diabetes study phase ii","volume":"59","author":"Chubb","year":"2022","journal-title":"Acta Diabetol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-1758","article-title":"An early-onset subgroup of type 2 diabetes: A multigenerational, prospective analysis in the Framingham heart study","volume":"43","author":"Echouffo-Tcheugui","year":"2020","journal-title":"Diabetes Care"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7570\/jomes20137","article-title":"Framingham risk score assessment in subjects with pre-diabetes and diabetes: A cross-sectional study in Korea","volume":"30","author":"Kwon","year":"2021","journal-title":"J Obes Metab Syndr"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1865_23","article-title":"Ten-year risk of cardiovascular events among the adult population of West Tripura district of India by the Framingham risk score: A cross-sectional study","volume":"13","author":"Paul","year":"2024","journal-title":"J Family Med Primary Care"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of Helsinki ethical principles for medical research involving human subjects","volume":"310","author":"World Med","year":"2013","journal-title":"Jama J Am Med Assoc"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(11)60276-6","article-title":"Subclinical thyroid disease","volume":"379","author":"Cooper","year":"2012","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.107.699579","article-title":"General cardiovascular risk profile for use in primary care - the Framingham heart study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12902-020-00586-5","article-title":"Sex differences in subclinical hypothyroidism and associations with metabolic risk factors: A health examination-based study in Mainland China","volume":"20","author":"Jiang","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/jog.15942","article-title":"The association between leptin and diabetes: A meta-analysis","volume":"50","author":"Wu","year":"2024","journal-title":"J Obstet Gynaecol Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2020.170285","article-title":"Differential effects of leptin administration on feeding and hpt axis function in early-life overfed adult rats","volume":"127","author":"de Gortari","year":"2020","journal-title":"Peptides"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-023-00877-z","article-title":"Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention","volume":"20","author":"Wong","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2007.02270.x","article-title":"Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in type 2 diabetic patients","volume":"24","author":"Chen","year":"2007","journal-title":"Diabetes Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e16097","article-title":"The potential relationship of coronary artery disease and hyperuricemia: A cardiometabolic risk factor","volume":"9","author":"Li","year":"2023","journal-title":"Heliyon"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-017-0413-y","article-title":"Cardiovascular morbidity and long term mortality associated with in hospital small increases of serum creatinine","volume":"31","author":"Losito","year":"2018","journal-title":"J Nephrol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-021-00486-z","article-title":"Cardiovascular risk prediction in healthy older people","volume":"44","author":"Neumann","year":"2022","journal-title":"Geroscience"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.942971","article-title":"Minor perturbations of thyroid homeostasis and major cardiovascular endpoints-physiological mechanisms and clinical evidence","volume":"9","author":"M\u00fcller","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/s13044-024-00199-3","article-title":"Increased thyroid stimulating hormone (Tsh) as a possible risk factor for atherosclerosis in subclinical hypothyroidism","volume":"17","author":"Alomair","year":"2024","journal-title":"Thyroid Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1080\/1354750x.2021.1989489","article-title":"Cystatin C and mortality risk in the general population: systematic review and dose response meta-analysis","volume":"27","author":"Jung","year":"2022","journal-title":"Biomarkers"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2009.07.019","article-title":"Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients","volume":"59","author":"Lee","year":"2010","journal-title":"Metab Clin Exp"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2020.1768849","article-title":"Cystatin C as a biomarker of chronic kidney disease: latest developments","volume":"20","author":"Benoit","year":"2020","journal-title":"Expert Rev Mol Diagn"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1871530","article-title":"Relationship between thyroid function and kidney function in patients with type 2 diabetes","volume":"2018","author":"Zhang","year":"2018","journal-title":"Int J Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1067801","article-title":"Association of thyroid function, within the euthyroid range, with cardiovascular risk: the epiporto study","volume":"13","author":"Neves","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2013.0314","article-title":"Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects","volume":"24","author":"Roef","year":"2014","journal-title":"Thyroid"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2011.0366","article-title":"Association between low serum free thyroxine concentrations and coronary artery calcification in healthy euthyroid subjects","volume":"22","author":"Kim","year":"2012","journal-title":"Thyroid"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(23)00227-9","article-title":"The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis","volume":"11","author":"Xu","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01854-9","article-title":"Real-world effectiveness of early insulin therapy on the incidence of cardiovascular events in newly diagnosed type 2 diabetes","volume":"9","author":"Luo","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaa073","article-title":"Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the Esc\/Easd: data from a large Mediterranean population","volume":"28","author":"Cebri\u00e1n-Cuenca","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e034626","DOI":"10.1161\/jaha.124.034626","article-title":"Sex differences in the association between cardiovascular autonomic neuropathy and mortality in patients with type 2 diabetes: the accord study","volume":"14","author":"Zhou","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.18632\/aging.204352","article-title":"Sex differences in major cardiovascular outcomes and fractures in patients with subclinical thyroid dysfunction: A systematic review and meta-analysis","volume":"14","author":"Fang","year":"2022","journal-title":"Aging-Us"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2017.32.10.1626","article-title":"The relationship between subclinical thyroid disease and cardiovascular disease risk score in Koreans","volume":"32","author":"Lim","year":"2017","journal-title":"J Korean Med Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-022-01415-7","article-title":"Association of high Bmi with subclinical hypothyroidism in young, first-episode and drug-naive patients with major depressive disorder: A large-scale cross-sectional study","volume":"273","author":"Kang","year":"2023","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1055\/a-2081-4599","article-title":"Alteration of lipid profile between subclinical hypothyroidism and well-matched controls: A meta-analysis","volume":"55","author":"Liu","year":"2023","journal-title":"Horm Metab Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1185782","article-title":"Increased 10-year cardiovascular disease risk in depressed patients with coexisting subclinical hypothyroidism","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2017.05.007","article-title":"Lipid and lipoprotein reference values from 133,450 Dutch lifelines participants: age- and gender-specific baseline lipid values and percentiles","volume":"11","author":"Balder","year":"2017","journal-title":"J Clin Lipidol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.12659\/msm.898134","article-title":"Serum lipid transfer proteins in hypothyreotic patients are inversely correlated with thyroid-stimulating hormone (Tsh) levels","volume":"22","author":"Skoczynska","year":"2016","journal-title":"Med Sci Monit"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2016.07.012","article-title":"Prevalence and predictors of hyperprolactinemia in subclinical hypothyroidism","volume":"35","author":"Sharma","year":"2016","journal-title":"Eur J Intern Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1365-2605.2006.00705.x","article-title":"Hypoandrogenaemia is associated with subclinical hypothyroidism in men","volume":"30","author":"Kumar","year":"2007","journal-title":"Int J Androl"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.sxmr.2019.02.005","article-title":"Testosterone deficiency and endothelial dysfunction: nitric oxide, asymmetric dimethylarginine, and endothelial progenitor cells","volume":"7","author":"Hotta","year":"2019","journal-title":"Sexual Med Rev"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S010","article-title":"Cardiovascular disease and\u00a0risk\u00a0management: standards of care in diabetes-2024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"B44","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13044-025-00233-y","article-title":"Hypothyroidism: playing the cardiometabolic risk concerto","volume":"18","author":"Kahaly","year":"2025","journal-title":"Thyroid Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.674841","article-title":"Levothyroxine treatment and cardiovascular outcomes in older people with subclinical hypothyroidism: pooled individual results of two randomised controlled trials","volume":"12","author":"Zijlstra","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13081231","article-title":"Assessment of risk factors and the relationship between hypothyroidism with hypertension in diabetes mellitus patients: A cross-sectional community-based study","volume":"13","author":"Shaphe","year":"2023","journal-title":"J Personalized Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab028","article-title":"Subclinical hypothyroidism represents visceral adipose indices, especially in women with cardiovascular risk","volume":"5","author":"Tsou","year":"202","journal-title":"J Endocr Soc"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jeae153","article-title":"Carotid plaque score is associated with 10-year major adverse cardiovascular events in low-intermediate risk patients referred to a general cardiology community clinic","volume":"26","author":"Matangi","year":"2025","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1635444\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T04:10:55Z","timestamp":1753935055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1635444\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":48,"alternative-id":["10.3389\/fendo.2025.1635444"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1635444","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"article-number":"1635444"}}